KEZAR LIFE SCIENCES INC (KZR) Stock Fundamental Analysis

NASDAQ:KZR • US49372L2097

6.7 USD
-0.06 (-0.89%)
Last: Feb 26, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

KZR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. The financial health of KZR is average, but there are quite some concerns on its profitability. KZR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • KZR had negative earnings in the past year.
  • In the past year KZR has reported a negative cash flow from operations.
  • In the past 5 years KZR always reported negative net income.
  • In the past 5 years KZR always reported negative operating cash flow.
KZR Yearly Net Income VS EBIT VS OCF VS FCFKZR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • KZR has a Return On Assets of -64.87%. This is in the lower half of the industry: KZR underperforms 60.65% of its industry peers.
  • With a Return On Equity value of -77.13%, KZR perfoms like the industry average, outperforming 53.17% of the companies in the same industry.
Industry RankSector Rank
ROA -64.87%
ROE -77.13%
ROIC N/A
ROA(3y)-42.23%
ROA(5y)-35.85%
ROE(3y)-50.4%
ROE(5y)-41.71%
ROIC(3y)N/A
ROIC(5y)N/A
KZR Yearly ROA, ROE, ROICKZR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for KZR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KZR Yearly Profit, Operating, Gross MarginsKZR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • KZR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for KZR has been increased compared to 1 year ago.
  • Compared to 5 years ago, KZR has less shares outstanding
  • Compared to 1 year ago, KZR has a worse debt to assets ratio.
KZR Yearly Shares OutstandingKZR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
KZR Yearly Total Debt VS Total AssetsKZR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • KZR has an Altman-Z score of -5.56. This is a bad value and indicates that KZR is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -5.56, KZR is doing worse than 62.76% of the companies in the same industry.
  • KZR has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • KZR's Debt to Equity ratio of 0.03 is in line compared to the rest of the industry. KZR outperforms 43.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -5.56
ROIC/WACCN/A
WACC9.32%
KZR Yearly LT Debt VS Equity VS FCFKZR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 7.29 indicates that KZR has no problem at all paying its short term obligations.
  • KZR has a better Current ratio (7.29) than 71.21% of its industry peers.
  • KZR has a Quick Ratio of 7.29. This indicates that KZR is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 7.29, KZR is doing good in the industry, outperforming 71.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.29
Quick Ratio 7.29
KZR Yearly Current Assets VS Current LiabilitesKZR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 34.47% over the past year.
  • The Revenue for KZR has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)34.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.96%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, KZR will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.65% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y38.2%
EPS Next 2Y29.96%
EPS Next 3Y20.86%
EPS Next 5Y12.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KZR Yearly Revenue VS EstimatesKZR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2029 2030 2031 2032 2033 100M 200M 300M
KZR Yearly EPS VS EstimatesKZR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • KZR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KZR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KZR Price Earnings VS Forward Price EarningsKZR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KZR Per share dataKZR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as KZR's earnings are expected to grow with 20.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.96%
EPS Next 3Y20.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • KZR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KEZAR LIFE SCIENCES INC

NASDAQ:KZR (2/26/2026, 8:00:02 PM)

6.7

-0.06 (-0.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-12
Inst Owners54.82%
Inst Owner Change8.01%
Ins Owners2.15%
Ins Owner Change0%
Market Cap49.04M
Revenue(TTM)N/A
Net Income(TTM)-70.79M
Analysts70
Price Target6.12 (-8.66%)
Short Float %3.14%
Short Ratio5.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.11%
Min EPS beat(2)13.72%
Max EPS beat(2)22.49%
EPS beat(4)4
Avg EPS beat(4)13.44%
Min EPS beat(4)4.91%
Max EPS beat(4)22.49%
EPS beat(8)7
Avg EPS beat(8)9.45%
EPS beat(12)9
Avg EPS beat(12)6.9%
EPS beat(16)12
Avg EPS beat(16)7.06%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.7%
EPS NY rev (3m)15.91%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-8.44
EYN/A
EPS(NY)-3.5
Fwd EYN/A
FCF(TTM)-8.78
FCFYN/A
OCF(TTM)-8.77
OCFYN/A
SpS0
BVpS12.54
TBVpS12.54
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -64.87%
ROE -77.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.23%
ROA(5y)-35.85%
ROE(3y)-50.4%
ROE(5y)-41.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.65%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.29
Quick Ratio 7.29
Altman-Z -5.56
F-Score2
WACC9.32%
ROIC/WACCN/A
Cap/Depr(3y)109.16%
Cap/Depr(5y)72.2%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.96%
EPS Next Y38.2%
EPS Next 2Y29.96%
EPS Next 3Y20.86%
EPS Next 5Y12.65%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.07%
OCF growth 3YN/A
OCF growth 5YN/A

KEZAR LIFE SCIENCES INC / KZR FAQ

What is the fundamental rating for KZR stock?

ChartMill assigns a fundamental rating of 2 / 10 to KZR.


What is the valuation status for KZR stock?

ChartMill assigns a valuation rating of 1 / 10 to KEZAR LIFE SCIENCES INC (KZR). This can be considered as Overvalued.


What is the profitability of KZR stock?

KEZAR LIFE SCIENCES INC (KZR) has a profitability rating of 0 / 10.


What is the expected EPS growth for KEZAR LIFE SCIENCES INC (KZR) stock?

The Earnings per Share (EPS) of KEZAR LIFE SCIENCES INC (KZR) is expected to grow by 38.2% in the next year.